Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-37,104
Closed -$6.09M 220
2017
Q1
$6.09M Sell
37,104
-215,691
-85% -$35.8M 0.33% 41
2016
Q4
$37M Buy
252,795
+119,619
+90% +$18M 2.15% 12
2016
Q3
$22.2M Sell
133,176
-20,906
-14% -$3.54M 0.83% 22
2016
Q2
$23.4M Buy
154,082
+10,596
+7% +$1.65M 1.22% 17
2016
Q1
$21.5M Buy
+143,486
New +$21.3M 1.08% 18
2014
Q3
Sell
-49,703
Closed -$6.49M 262
2014
Q2
$5.88M Buy
49,703
+7,392
+17% +$856K 0.25% 56
2014
Q1
$5.22M Buy
+42,311
New +$5.13M 0.29% 62

Other funds holding AMGN

Sabby Management's AMGN Position: Q2 2017 in Review

Sabby Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 37,104 shares — an estimated $6.09M sold.

Sabby Management first reported a position in AMGN in Q1 2014 and held it in 7 quarters. The position peaked at $37M in Q4 2016. 1,596 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Sabby Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Sabby Management sold 37,104 Amgen shares in Q2 2017, an estimated $6.09M.
  • Sabby Management first reported a position in Amgen in Q1 2014 and held it in 7 quarters.
  • Sabby Management's Amgen position peaked at $37M in Q4 2016.
  • 1,596 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Sabby Management's 13F filing for Q2 2017, filed 14 Aug 2017.